Pfizer Restores Smoking Cessation Drug: Here’s Why

The drug, called Chantix, was approved by the US Food and Drug Administration in May 2006 as a prescription drug that helps adults aged 18 and over to quit smoking and is used for 12-24 weeks. In the past months, the drug causing cancer disclosed and investigations started.

Pharmaceutical giant Pfizer, one of the leading companies in the world, is a drug used to treat smoking addiction. chantix He decided to recall his drug named nitrosamine, which causes cancer. The US Drug and Food Administration (FDA) said in a statement that it could potentially lead to an increased risk of cancer in humans, but for patients taking this drug. there is no immediate risk expressed.

All versions will be collected

According to the information shared by the US Drug and Food Administration (FDA), Chantix is ​​sold as 0.5 mg and 1 mg. all versions will be collected. The FDA said in a statement that it could potentially lead to an increased risk of cancer, but that there is no immediate risk to patients using the drug, adding that pharmacists should continue to take their current medication until they supply a new drug or their doctor prescribes a different treatment.

Pfizer has recently carcinogenic effect He had not received any reports of adverse events related to the recall after its discovery, but advised patients taking Chantix to consult their physician to confirm whether they were receiving an affected batch and to seek treatment options, if appropriate.